KIDS · Orthopediatrics Corp
$24.80
-0.21 (-0.84%)
At close · Aug 14
Market Cap
$647.52M
Shares
26.11M
Orthopediatrics Corp Earnings Call Transcripts
Every quarterly earnings call for Orthopediatrics Corp (KIDS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲39.4%
$34.95M
$18.54M
'22 Q3
22-10-31
▲24.9%
$30.99M
−$7.85M
'22 Q4
23-02-28
▲34.9%
$31.59M
−$6.81M
'23 Q1
23-05-01
▲20.1%
$39.56M
−$2.89M
'23 Q2
23-07-31
▲14.4%
$39.97M
−$4.59M
'23 Q3
23-11-06
▲21.4%
$37.61M
−$6.69M
'23 Q4
24-03-06
▲41.5%
$44.69M
−$7.80M
'24 Q1
24-05-06
▲33.5%
$52.80M
−$6.03M
'24 Q2
24-08-05
▲36.5%
$54.57M
−$7.92M
'24 Q3
24-11-06
▲40%
$52.67M
−$16.07M
'24 Q4
25-01-13
▲17.3%
$52.41M
−$10.66M
'25 Q1
25-05-07
▲15.7%
$61.08M
−$7.11M
'25 Q2
25-08-05
▲12.2%
$61.25M
−$11.77M
'25 Q3
25-10-28
▲17%
$61.60M
−$10.10M
'25 Q4
26-02-26
▲13.3%
$59.36M
−$10.69M
'26 Q1
26-04-30
LATEST
▲15.4%
$70.51M
−$7.16M
'26 Q2
26-08-04
Conference
Investor event
2026-08-12
Canaccord Genuity 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-04
Q2 2026 OrthoPediatrics Corp. Earnings Conference Call
Revenue
$70.51M
▲ 15.4% YoY Diluted EPS
$-0.30
Gross margin
74.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Orthopediatrics Corp Q1 FY2026 Earnings Call
Confident tone
Innovation super cycle / new product launches
Capital allocation and growth-investment trade-off
Specialty bracing (OPSB)
Revenue
$59.36M
▲ 13.3% YoY Diluted EPS
$-0.45
Gross margin
73.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Orthopediatrics Corp Q4 FY2025 Earnings Call
Confident tone
Scoliosis and spine franchise
International / EU MDR opportunity
Revenue and profitability performance
Revenue
$61.60M*
▲ 17% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Orthopediatrics Corp Q3 FY2025 Earnings Call
Positive tone
Profitability and Free Cash Flow
Revenue Shortfall Drivers
OPSB Specialty Bracing Expansion
Revenue
$61.25M
▲ 12.2% YoY Diluted EPS
$-0.50
Gross margin
73.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Orthopediatrics Corp Q2 FY2025 Earnings Call
Confident tone
International markets
OPSB / clinic expansion
Scoliosis / EOS portfolio
Revenue
$61.08M
▲ 15.7% YoY Diluted EPS
$-0.30
Gross margin
72.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Orthopediatrics Corp Q1 FY2025 Earnings Call
Confident tone
OPSB scaling and launches
Profitability and cash flow improvement
International and European expansion
Revenue
$52.41M
▲ 17.3% YoY Diluted EPS
$-0.46
Gross margin
73.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Orthopediatrics Corp Q4 FY2024 Earnings Call
Confident tone
OPSB (Pediatric Specialty Bracing) expansion
Scoliosis growth and product launches
Market share gains in trauma and deformity
Revenue
$52.67M*
▲ 40% YoY Gross margin
67.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Orthopediatrics Corp Q3 FY2024 Earnings Call
Confident tone
OrthoPediatrics Specialty Bracing (OPSB)
Scoliosis and Enabling Technology (7D)
Trauma and Deformity (T&D) Business
Revenue
$54.57M
▲ 36.5% YoY Diluted EPS
$-0.34
Gross margin
73.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Orthopediatrics Corp Q2 FY2024 Earnings Call
Confident tone
Specialty bracing / Boston O&P acquisition
Scoliosis business and international volatility
Trauma and deformity growth
Revenue
$52.80M
▲ 33.5% YoY Diluted EPS
$-0.26
Gross margin
77.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Orthopediatrics Corp Q1 FY2024 Earnings Call
Confident tone
OPSB / Boston O&P acquisition
Scoliosis (ApiFix, fusion, EOS)
Trauma and Deformity / Pega / PNP Tibia
Revenue
$44.69M
▲ 41.5% YoY Diluted EPS
$-0.34
Gross margin
72.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
Orthopediatrics Corp Q4 FY2023 Earnings Call
Confident tone
Record revenue and growth
Boston O&P acquisition
Scoliosis business
Revenue
$37.61M*
▲ 21.4% YoY Gross margin
71.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Orthopediatrics Corp Q3 FY2023 Earnings Call
Revenue
$39.97M
▲ 14.4% YoY Diluted EPS
$-0.20
▼ 123% YoY Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-31
Orthopediatrics Corp Q2 FY2023 Earnings Call
Revenue
$39.56M
▲ 20.1% YoY Diluted EPS
$-0.13
Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
Orthopediatrics Corp Q1 FY2023 Earnings Call
Revenue
$31.59M
▲ 34.9% YoY Diluted EPS
$-0.30
Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Orthopediatrics Corp Q4 FY2022 Earnings Call
Revenue
$30.99M*
▲ 24.9% YoY Gross margin
68.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-31
Orthopediatrics Corp Q3 FY2022 Earnings Call
Revenue
$34.95M
▲ 39.4% YoY Diluted EPS
$0.87
Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Orthopediatrics Corp Q2 FY2022 Earnings Call
Revenue
$32.93M
▲ 23.3% YoY Diluted EPS
$-0.02
Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Orthopediatrics Corp Q1 FY2022 Earnings Call
Revenue
$23.42M
▲ 9.1% YoY Diluted EPS
$-0.47
Gross margin
79.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Orthopediatrics Corp Q4 FY2021 Earnings Call
Revenue
$24.81M
▲ 31.1% YoY Diluted EPS
$0.00
Gross margin
72.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Orthopediatrics Corp Q3 FY2021 Earnings Call
Revenue
$25.08M
▲ 12.9% YoY Diluted EPS
$-0.11
Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Orthopediatrics Corp Q2 FY2021 Earnings Call
Revenue
$26.70M
▲ 96.4% YoY Diluted EPS
$-0.19
Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Orthopediatrics Corp Q1 FY2021 Earnings Call
Revenue
$21.46M
▲ 31.2% YoY Diluted EPS
$-0.54
Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Orthopediatrics Corp Q4 FY2020 Earnings Call
Revenue
$18.92M
▼ 0.1% YoY Diluted EPS
$-0.73
Gross margin
79.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Orthopediatrics Corp Q3 FY2020 Earnings Call
Revenue
$22.20M
▲ 7% YoY Diluted EPS
$-0.24
Gross margin
79.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Orthopediatrics Corp Q2 FY2020 Earnings Call
Revenue
$13.59M
▼ 25.3% YoY Diluted EPS
$-0.54
Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Orthopediatrics Corp Q1 FY2020 Earnings Call
Revenue
$16.36M
▲ 11.6% YoY Diluted EPS
$-0.30
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–28 of 28 earnings calls
Key facts
CIK
1425450
CUSIP
68752L100
13F (30d)
113 filings
113 filers
Visit website
Investor relations